Dr. James T. Highsmith, MD, MS

Dr. Highsmith practices at James Highsmith MD in Lutz, Florida.

Dr. Highsmith's NPI, 1760427165, was assigned on June 19, 2006. Dr. Highsmith graduated from USF Health Morsani College of Medicine in 2010. Dr. Highsmith holds Florida license ME124442.

Dr. Highsmith's primary practice is James Highsmith MD, at 1809 Collier Pkwy, Lutz, FL 33549 in Hillsborough County. The practice phone is (813) 979-0000.

Dr. Highsmith's primary practice is James Highsmith MD in Lutz, Florida. The medical group on file is Florida Dermatology and Skin Cancer Centers. Dmand AI also links Dr. Highsmith to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Highsmith practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Highsmith's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Highsmith is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Highsmith's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, itchy rashes and joint cyst among the conditions Dr. Highsmith treats.

CMS data shows 1,671 Medicare services from Dr. Highsmith across 21 procedure codes in 2024, for 318 Medicare patients. Medicare paid $170,014 for them. Every service was in an office.

CMS counts 318 Medicare patients who saw Dr. Highsmith in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Highsmith's median patient age at 75, with 42% women.

In 2024, Dr. Highsmith wrote 875 Medicare Part D claims for 484 patients. 98% of them were for generic drugs. CMS names the drug for 806 of them, across 17 drugs with 11 or more claims each, at $10,207 in total drug cost. In 2023, CMS named 436 claims across 12 drugs.

Dr. Highsmith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 224 procedures of melanoma (skin cancer) excision by Dr. Highsmith, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Highsmith in 2016. 2016 was the busiest year, with 2. The most frequent topics are Mohs Surgery. Dr. Highsmith has published most often in Technol Innov. Dr. Highsmith's most frequent co-authors are Jeremy R. Etzkorn, MD and Lavanya Parachuru Krishnan, MD.

CMS Open Payments shows 33 general payments to Dr. Highsmith from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Organogenesis Inc. paid the most, $145.

Dr. Highsmith graduated from USF Health Morsani College of Medicine in 2010.

Dr. Highsmith is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.